Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
APSC for aging-related diseases
- Development stage
- Preclinical
- Lead developer
- APstem Therapeutics
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Systemic, Local
01
Overview
APSC (Activated Pluripotent Stem Cell) is an allogeneic, off-the-shelf cell therapy being developed by APstem Therapeutics for the treatment of aging-related diseases. The therapy utilizes guide-integrated adult stem cells (giaSCs), which are created through a proprietary process that fuses immunoregulatory guide cells from adult peripheral blood with mesenchymal stromal cells derived from umbilical cord tissue. These cells are designed to possess high plasticity, low immunogenicity, and non-tumorigenic properties without the need for genetic reprogramming. The mechanism of action involves counteracting aging-related tissue decline through regenerative and repair processes. Currently in preclinical development, APSC can be administered either systemically or locally to address various age-associated conditions.
- Other names
- Activated Pluripotent Stem Cells for aging-related diseasesguide-integrated adult stem cellsgenomically-induced Activated Stem Cells
Beyond the preview
Go deeper on APSC for aging-related diseases.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on APSC for aging-related diseases.